Breaking News, Collaborations & Alliances

Eisai & Boston University School of Medicine Enter Partnership

To study the effects of Alzheimer's disease-associated genetic variants

Eisai and Boston University School of Medicine have formed a research collaboration to study the effects of Alzheimer’s disease-associated genetic variants on the behavior of brain cells, called microglia.    Under the two-year agreement, Eisai’s immuno-dementia discovery research team at its Andover innovative Medicines (AiM) Institute will work with principal investigator Tsuneya Ikezu, M.D., Ph.D., Professor of Pharmacology & Experimental Therapeutics and Neurology at ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters